Strata Critical Medical (SRTA) Other Operating Expenses (2019 - 2026)

Strata Critical Medical has disclosed Other Operating Expenses across 8 years of filings, most recently posting $1.5 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 467.82% year-over-year to $1.5 million; the TTM figure through Mar 2026 stood at -$6.4 million (down 0.63% YoY), while the FY2025 annual figure was $2.6 million, up 235.2% from the prior year.
• Other Operating Expenses climbed to $1.5 million in Q1 2026, from -$100.7 million in the prior quarter.
• Over the last five years, Other Operating Expenses for SRTA reached as high as $58.5 million in Q3 2023 and fell as low as -$100.7 million in Q4 2025.
• The 5-year median for Other Operating Expenses is $38.2 million (2025), against an average of $12.0 million.
• Annual changes were most pronounced in 2022 — Other Operating Expenses slumped 380.4% — and 2026, when it surged 467.82%.
• A 5-year view of Other Operating Expenses shows it stood at -$21.3 million in 2022, then soared by 291.87% to $40.9 million in 2023, then slumped by 317.23% to -$88.8 million in 2024, then dropped by 13.44% to -$100.7 million in 2025, then soared by 101.48% to $1.5 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $1.5 million, -$100.7 million, and $38.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.